Literature DB >> 30485558

Liquid biopsy: A new avenue in pathology.

Ratan Kumar Ghosh1, Tushar Pandey2, Pranab Dey3.   

Abstract

Liquid biopsy is a relatively new entity. This non-invasive technique provides real-time information about a tumour. The liquid biopsy contains circulating tumour cells, cell-free DNA and exosomes. The main indications for liquid biopsy include early diagnosis, screening, detection of minimal residual disease, designing personalised treatment and predicting biological behaviour of the tumour. In this review, we discuss various aspects of liquid biopsy and compare it with conventional biopsy.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cell-free DNA; exosome; liquid biopsy; technology

Mesh:

Substances:

Year:  2019        PMID: 30485558     DOI: 10.1111/cyt.12661

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  8 in total

Review 1.  Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and Thrombosis.

Authors:  Elham Ghorbanpour; David Lillicrap
Journal:  Semin Thromb Hemost       Date:  2019-08-12       Impact factor: 4.180

2.  Next generation sequencing data for use in risk assessment.

Authors:  B Alex Merrick
Journal:  Curr Opin Toxicol       Date:  2019-03-08

3.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

4.  Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors.

Authors:  Kit Man Chan; Jonathan Gleadle; Jordan Li; Thomas Danny Michl; Krasimir Vasilev; Melanie MacGregor
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.996

Review 5.  Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer.

Authors:  Giulia Marvaso; Stefania Volpe; Matteo Pepa; Mattia Zaffaroni; Giulia Corrao; Matteo Augugliaro; Franco Nolè; Ottavio De Cobelli; Barbara Alicja Jereczek-Fossa
Journal:  Cancer Manag Res       Date:  2022-01-06       Impact factor: 3.989

Review 6.  Diagnostic challenges in the gray-zone lesions of fine-needle aspiration cytology.

Authors:  Shruti Gupta; Pranab Dey
Journal:  Cytojournal       Date:  2021-09-10       Impact factor: 2.091

Review 7.  Immune status for monitoring and treatment of bladder cancer.

Authors:  Shen Pan; Shijie Li; Yunhong Zhan; Xiaonan Chen; Ming Sun; Xuefeng Liu; Bin Wu; Zhenhua Li; Bitian Liu
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

8.  Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.

Authors:  Hsiang-Ling Ho; Fang-Yu Wang; Chi-Lu Chiang; Chun-Ming Tsai; Chao-Hua Chiu; Teh-Ying Chou
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.